MP
ZURA icon

Mangrove Partners’s Zura Bio ZURA Stock Holding History

Mangrove Partners’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,791
Closed -$88K – 600
2026
Q1 		$88K Buy
+14,791
New +$89.3K 0.01% 401

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mangrove Partners's ZURA Position: Q2 2026 in Review

Mangrove Partners sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 14,791 shares — an estimated $88K sold.

Mangrove Partners first reported a position in ZURA in Q1 2026 and held it in 1 quarter. The position peaked at $88K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Mangrove Partners reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Mangrove Partners sold 14,791 Zura Bio shares in Q2 2026, an estimated $88K.
  • Mangrove Partners first reported a position in Zura Bio in Q1 2026 and held it in 1 quarter.
  • Mangrove Partners's Zura Bio position peaked at $88K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.